Distribuzione geografica
Continente #
NA - Nord America 570
EU - Europa 366
AS - Asia 116
OC - Oceania 23
AF - Africa 9
SA - Sud America 9
Totale 1.093
Nazione #
US - Stati Uniti d'America 548
GB - Regno Unito 159
IT - Italia 86
DE - Germania 39
IN - India 33
CZ - Repubblica Ceca 29
AU - Australia 23
CA - Canada 20
SG - Singapore 18
TR - Turchia 17
FR - Francia 13
FI - Finlandia 12
HK - Hong Kong 12
CN - Cina 10
JP - Giappone 7
NL - Olanda 7
BR - Brasile 4
ET - Etiopia 4
ID - Indonesia 4
UA - Ucraina 4
CL - Cile 3
IR - Iran 3
PL - Polonia 3
SA - Arabia Saudita 3
BE - Belgio 2
CH - Svizzera 2
KZ - Kazakistan 2
MA - Marocco 2
PA - Panama 2
RU - Federazione Russa 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
CY - Cipro 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
Totale 1.093
Città #
Ashburn 255
London 147
Rome 43
Boardman 34
Council Bluffs 32
San Francisco 30
Brno 29
Seattle 28
Pune 26
West Jordan 22
Toronto 17
Washington 16
Singapore 13
Canberra 12
Helsinki 12
Munich 12
Los Angeles 11
New York 10
Melbourne 7
Amsterdam 6
Redmond 6
Tokyo 6
Paris 5
Central 4
Frankfurt am Main 4
Sydney 4
Addis Ababa 3
Bologna 3
Brownsville 3
Haikou 3
Hong Kong 3
Milan 3
Riyadh 3
Warsaw 3
Anderlecht 2
Andover 2
Berlin 2
Boydton 2
Cervignano del Friuli 2
Cinisello Balsamo 2
Delhi 2
Falls Church 2
Ferrara di Monte Baldo 2
Foligno 2
Guangzhou 2
Hanover 2
Houston 2
Kharkiv 2
Naples 2
Newark 2
Perugia 2
Rabat 2
Rovereto 2
Santa Clara 2
Shanghai 2
São Paulo 2
Torino 2
Almere Stad 1
Basingstoke 1
Bratislava 1
Budapest 1
Chantilly 1
Charlotte 1
Chisinau 1
Ciampino 1
Cleveland 1
Cold Lake 1
Des Plaines 1
Dhaka 1
Dublin 1
Fairport 1
Freetown 1
Gauteng 1
Hyderabad 1
Jena 1
Jersey City 1
Johannesburg 1
Kyiv 1
Lima 1
Lincoln 1
Luxembourg 1
L’Aquila 1
Markham 1
Miami 1
Nicosia 1
Panama City 1
Redwood City 1
Reykjavik 1
San Antonio 1
Sarajevo 1
Secaucus 1
Sewanee 1
Siena 1
Sofia 1
Stoney Creek 1
Stow 1
Surabaya 1
Tappahannock 1
Taranto 1
Temecula 1
Totale 904
Nome #
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 17
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 17
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 16
Reply 15
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 15
GH-resistance in different stages of chronic liver disease 15
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 15
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 14
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 14
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 13
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 13
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 13
Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 12
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 12
AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement 12
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 12
[A 73-year-old woman with vomiting and metabolic alkalosis] 12
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 12
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 11
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 11
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 11
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 11
Tubercolomi cerebrali multipli resistenti alla terapia convenzionale in un soggetto immunosoppresso [Multiple cerebral tuberculomas resistant to conventional therapy in an immunocompromised subject] 11
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 11
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 11
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 11
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 10
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 10
The pharmacological treatment of chronic comorbidities in COPD: mind the gap! 10
Effect of sibutramine on plasma C-reactive protein, leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials 10
non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. 10
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 10
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 10
The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen 10
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 9
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 9
TNF-alpha and growth hormone resistance in patients with chronic liver disease 9
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 9
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 9
Raised C-reactive protein levels in patients with recent onset type 1 diabetes 9
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 9
Advances in management of periprosthetic joint infections: an historical prospective study 9
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 9
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 9
Factors enhancing treatment of hepatitis C virus⇓infected italian people who use drugs: The CLEO-GRECAS experience 9
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 9
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 9
The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period 9
Reply 8
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 8
[A 61-year-old woman with abdominal pain and urination disorders] 8
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 8
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 8
Uomo di 67 anni con dolore addominale, anoressia, febbricola [67 year old man with abdominal pain, anorexia and low-grade fever] 8
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 8
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 8
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 8
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 8
Liver involvement in the course of thymoma-associated multiorgan autoimmunity: The first histological description 8
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 7
Role of SIRT-3, p-mTOR and HIF-1 in hepatocellular carcinoma patients affected by metabolic dysfunctions and in chronic treatment with metformin 7
Severe hypophosphatemic osteomalacia secondary to fanconi syndrome due to adefovir: a case report 7
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 7
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 7
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia. 7
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 7
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 7
Associations between the IGF system and inflammatory markers in inflammatory bowel disease: authors’ reply 7
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 6
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 6
Westernization of the Filipino population resident in Rome: obesity, diabetes and hypertension 6
A challenging alfa-fetoprotein in a cirrhotic patient 6
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 6
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 6
Risk factors for hospital readmission of elderly patients 6
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency. 6
Reelin expression in human liver of patients with chronic hepatitis C infection 6
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 6
Hepatic matrix metalloproteinase-10 exerts a hepatoprotective role after acute liver inury 6
Lipophagy Impairment Is Associated With Disease Progression in NAFLD 6
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 6
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 5
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 5
Gas exchanges and pulmonary vascular abnormalities at different stages of chronic liver disease 5
Hepatic complications of bariatric surgery : the reverse side of the coin 5
The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention 5
Proton pump inhibitor prescription abuse and sepsis in cirrhosis 5
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 5
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 5
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 5
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma 5
Liver cirrhosis after prolonged therapy with IFN-alpha plus IL-2 in a metastatic renal cancer long-term survivor 5
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 5
Boosting pigment epithelial-derived factor: a promising approach for the treatment of early portal hypertension 5
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 5
Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol 5
Assessment of liver function by the exhaled breath-print during chronic liver disease 5
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 5
Totale 873
Categoria #
all - tutte 40.951
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.951

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022341 0 2 8 0 3 3 2 6 47 4 4 262
2022/2023114 13 1 7 4 10 2 30 4 3 5 33 2
2023/2024647 26 51 19 62 62 275 2 37 8 41 20 44
2024/202533 33 0 0 0 0 0 0 0 0 0 0 0
Totale 1.135